High-Dose Cholinergic Therapy With Rivastigmine Patch Does Not Prolong QTc Time in Patients With Alzheimer’s Disease

Journal of Clinical Psychiatry - United States
doi 10.4088/jcp.13l08730
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Physicians Postgraduate Press, Inc

Related search

A Single Supratherapeutic Dose of Vorinostat Does Not Prolong the QTc Interval in Patients With Advanced Cancer

Clinical Cancer Research
Cancer ResearchOncology
2009English

Lamotrigine Does Not Prolong QTc in a Thorough QT/QTc Study in Healthy Subjects

British Journal of Clinical Pharmacology
Pharmacology
2008English

Melatonin Therapy in Patients With Alzheimer’s Disease

Antioxidants
BiochemistryClinical BiochemistryCell BiologyMolecular BiologyPhysiology
2014English

Ciprofloxacin Does Not Prolong the QTc Interval: A Clinical Study in ICU Patients and Review of the Literature

Journal of Pharmacy and Pharmaceutical Sciences
MedicinePharmacologyPharmaceutical Science
2017English

Pharmacokinetics of a Novel Transdermal Rivastigmine Patch for the Treatment of Alzheimer’s Disease: A Review

International Journal of Clinical Practice
Medicine
2009English

High-Dose Aspirin Is Associated With Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease

PLoS ONE
Multidisciplinary
2015English

Adjuvant Oestrogen Therapy Does Not Improve Disease Activity in Postmenopausal Patients With Rheumatoid Arthritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1993English

High Dose Intravenous Methylprednisolone Pulse Therapy in Patients With Rheumatoid Arthritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1990English

Patch Testing in Pediatric Patients With Atopic Disease

Journal of Allergy and Clinical Immunology
AllergyImmunology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy